Investigation on abnormal gene loci of a Chinese pedigree with hereditary combined deficiency of blood coagulation factor XI, XII, and protein S.

[1]  T. Renné,et al.  Coagulation factor XII in thrombosis and inflammation. , 2018, Blood.

[2]  B. Dahlbäck.  Vitamin K–Dependent Protein S: Beyond the Protein C Pathway , 2017, Seminars in Thrombosis and Hemostasis.

[3]  T. Renné,et al.  Contact system revisited: an interface between inflammation, coagulation, and innate immunity , 2016, Journal of thrombosis and haemostasis : JTH.

[4]  K. Meijer,et al.  A novel c.290G>A mutation in the Factor 11 gene in a Dutch Caucasian family with a Factor XI deficiency. , 2015, Thrombosis research.

[5]  A. Mumford,et al.  Guideline for the diagnosis and management of the rare coagulation disorders , 2014, British journal of haematology.

[6]  T. Renné,et al.  Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo , 2009, Cell.

[7]  U. Seligsohn.  Factor XI deficiency in humans , 2009, Journal of thrombosis and haemostasis : JTH.

[8]  J. van der Meer,et al.  Protein S deficiency: a clinical perspective , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  B. Dahlbäck,et al.  Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. , 2008, Blood.

[10]  T. Renné,et al.  Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.

[11]  James H Morrissey,et al.  Polyphosphate modulates blood coagulation and fibrinolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Marín,et al.  Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction , 2005, Thrombosis and Haemostasis.

[13]  M. Margaglione,et al.  Molecular diversity and thrombotic risk in protein S deficiency: The PROSIT study , 2005, Human mutation.

[14]  H. Kluin-Nelemans,et al.  Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test‐based classification , 2005, British journal of haematology.

[15]  T. Dang,et al.  Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. , 2004, Blood.

[16]  S. Humphries,et al.  Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. , 2002, Atherosclerosis.

[17]  F. Bauduer,et al.  Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. , 2002, Blood.

[18]  J. Lavinha,et al.  Molecular Genetic Analysis of Factor XI Deficiency: Identification of Five Novel Gene Alterations and the Origin of Type II Mutation in Portuguese Families , 2000, Thrombosis and Haemostasis.

[19]  J. Meijers,et al.  Role of blood coagulation factor XI in downregulation of fibrinolysis , 2000, Current opinion in hematology.

[20]  D. Martincic,et al.  Factor XI messenger RNA in human platelets. , 1999, Blood.

[21]  M. Mitchell,et al.  Identification of a novel mutation in a non‐Jewish factor XI deficient kindred , 1999, British journal of haematology.

[22]  N. Hamasaki,et al.  A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. , 1998, Blood.

[23]  B. Lämmle,et al.  Mutations in the human factor XII gene. , 1997, Blood.

[24]  M. Mittelman,et al.  The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. , 1997, Blood.

[25]  A. Chetrit,et al.  One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. , 1995, Blood.

[26]  D. Green,et al.  Protein S deficiency in middle‐aged women with stroke , 1992, Neurology.

[27]  E. Davie,et al.  Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. , 1992, Blood.

[28]  K. Fujikawa,et al.  Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. , 1991, Biochemistry.

[29]  S. Kawabata,et al.  Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitution. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Davie,et al.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. MacGillivray,et al.  Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. , 1987, The Journal of biological chemistry.

[32]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.

[33]  Chan Li,et al.  An update on factor XI structure and function. , 2018, Thrombosis research.

[34]  T. Renné,et al.  Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[35]  V. Pilli,et al.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule. , 2016, JSM biochemistry and molecular biology.

[36]  E. Neshkova,et al.  Contact System. New Concepts on Activation Mechanisms and Bioregulatory Functions , 2004, Biochemistry (Moscow).